| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/31/2002 | US20020012664 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian CC-chemokine receptor 2, mammalian CC-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 01/31/2002 | US20020012661 Methods for introducing genes into mammalian subjects |
| 01/31/2002 | US20020012658 Prevention and treatment of verotoxin-induced disease |
| 01/31/2002 | DE10033750A1 Pathogenresistenz in Organismen Pathogen resistance in organisms |
| 01/31/2002 | CA2725819A1 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/31/2002 | CA2418333A1 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | CA2418282A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | CA2418204A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2418199A1 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2418194A1 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 01/31/2002 | CA2417192A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | CA2417188A1 Bacteriophage having multiple host range |
| 01/31/2002 | CA2417134A1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | CA2416761A1 Method for screening peptides for use in immunotherapy |
| 01/31/2002 | CA2416751A1 Alpha v integrin receptor antagonists |
| 01/31/2002 | CA2416750A1 Compounds having mif antagonist activity |
| 01/31/2002 | CA2416733A1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | CA2416691A1 Proteases |
| 01/31/2002 | CA2416664A1 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | CA2416657A1 Fh-binding protein of streptococcus pneumoniae |
| 01/31/2002 | CA2416488A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | CA2415900A1 Uses for nad synthetase inhibitors |
| 01/31/2002 | CA2415740A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | CA2415586A1 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 01/31/2002 | CA2415585A1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 01/31/2002 | CA2415368A1 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/31/2002 | CA2410766A1 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2410683A1 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs |
| 01/31/2002 | CA2410682A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/30/2002 | EP1176192A2 Helicobacter felis vaccine |
| 01/30/2002 | EP1175912A1 Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 01/30/2002 | EP1175911A2 Uses of recombinant colony stimulating factor-1 for treatment of leukopenia |
| 01/30/2002 | EP1175905A1 Nutritional Composition |
| 01/30/2002 | EP1175503A1 49 human secreted proteins |
| 01/30/2002 | EP1175502A1 Halo- or hydroxy-substituted nocathiacin antibiotics |
| 01/30/2002 | EP1175498A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells |
| 01/30/2002 | EP1175497A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 01/30/2002 | EP1175489A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 01/30/2002 | EP1175446A1 Human antibodies that bind human il-12 and methods for producing |
| 01/30/2002 | EP1175440A1 48 human secreted proteins |
| 01/30/2002 | EP1175435A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 01/30/2002 | EP1175433A1 Androgen glycosides and androgenic activity thereof |
| 01/30/2002 | EP1175432A1 Processes for the synthesis of oligomers using phusphoramidite compositions |
| 01/30/2002 | EP1175430A1 Antisense-oligos with better stability and antisense effect |
| 01/30/2002 | EP1175429A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a |
| 01/30/2002 | EP1175428A1 3-deoxy-desmycosin derivatives and process for their preparation |
| 01/30/2002 | EP1175417A1 Substituted benzolactam compounds |
| 01/30/2002 | EP1175403A1 6,7-disubstituted-5,8-quinolinedione derivatives as an antifungal agent |
| 01/30/2002 | EP1175402A1 Piperidine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175401A1 Piperazine derivatives useful as ccr5 antagonists |
| 01/30/2002 | EP1175385A1 D-mannitol derivatives as hiv aspartyl protease inhibitors |
| 01/30/2002 | EP1175246A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 01/30/2002 | EP1175224A2 Pegylated interferon alfa-ccr5 antagonist combination hiv therapy |
| 01/30/2002 | EP1175223A2 Methods and compositions for modulating an immune response |
| 01/30/2002 | EP1175222A2 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections |
| 01/30/2002 | EP1175214A2 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 01/30/2002 | EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/30/2002 | EP1175205A2 Inhibitors of crystallization in a solid dispersion |
| 01/30/2002 | EP1175149A1 Disinfecting composition based on h2o2, acids and metal ions |
| 01/30/2002 | EP1175148A1 Infection resistant polymers, their preparation and uses |
| 01/30/2002 | EP1175144A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/30/2002 | EP0904284B1 6-substituted amino-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives as cysteine protease inhibitors |
| 01/30/2002 | EP0868183B1 Injectable quinolone formulations |
| 01/30/2002 | EP0866791B1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| 01/30/2002 | EP0832198A4 Oxygen activatable formulations for disinfection or sterilization |
| 01/30/2002 | EP0724571B1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 01/30/2002 | CN1333873A HIV-specfic T-cell induction |
| 01/30/2002 | CN1333785A Interferon-beta fusion proteins and uses |
| 01/30/2002 | CN1333783A Macrolide intermediates in the preparation of clarithromycin |
| 01/30/2002 | CN1333782A New derivatives of erythromycin, process for making them and use as medicaments |
| 01/30/2002 | CN1333776A Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum |
| 01/30/2002 | CN1333770A Novel dicyclic compound |
| 01/30/2002 | CN1333769A Thiourea inhibitors of herps viruses |
| 01/30/2002 | CN1333766A Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds as factor xainhibitors |
| 01/30/2002 | CN1333765A Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 01/30/2002 | CN1333754A Benzoheterocycles and their use as MEK inhibitors |
| 01/30/2002 | CN1333753A Quinolinecarboxamides as antiviral agents |
| 01/30/2002 | CN1333750A Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 01/30/2002 | CN1333693A ordered molecualr presentation of antigens, method of preparation and use |
| 01/30/2002 | CN1333692A I (mycobacterium tuberculosis) superoxide dismutase |
| 01/30/2002 | CN1333680A Oral formulation for gastrointestinal drug delivery |
| 01/30/2002 | CN1333378A Diagnose test |
| 01/30/2002 | CN1333339A Polytype gene of MXA protein and application thereof |
| 01/30/2002 | CN1333338A Papilloma pseudovirus and process for preparing same |
| 01/30/2002 | CN1333207A Sparfloxacin salt and synthesis method and use thereof |
| 01/30/2002 | CN1333052A Lotion for beriberi |
| 01/30/2002 | CN1333049A Anti common cold chewing gum |
| 01/30/2002 | CN1333034A Skin disease ointment and preparation process thereof |
| 01/30/2002 | CN1078614C Process for producing high-molecular-weight compounds of phenolic compounds etc, and use thereof |
| 01/29/2002 | US6343258 Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content |
| 01/29/2002 | US6342596 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 01/29/2002 | US6342537 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/29/2002 | US6342521 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 01/29/2002 | US6342510 Antiinflammatory agents and enzyme inhibitors |
| 01/29/2002 | US6342509 Antiasthmatics, antihistamines or bronchodialators |
| 01/29/2002 | US6342505 Use of 4-substituted tetrahydropyridines for making medicines acting on TGF-β1 |
| 01/29/2002 | US6342502 Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases |